Clinical Validation of Nerveblox, an Artificial Intelligence Software to Support Ultrasound-Guided Regional Anesthesia Procedures
Data Collection for the Validation of an AI Software to Support Ultrasound-Guided Regional Anesthesia Procedures
1 other identifier
interventional
40
1 country
1
Brief Summary
This single-center, prospective study is being conducted at AABP Integrative Pain Care and Wellness in Brooklyn, New York, USA. The aim of this study is to collect ultrasound images from healthy volunteers and evaluate the performance of the Nerveblox software using this image dataset. Nerveblox is a software as a medical device which is designed to assist anesthesiologist for ultrasound-guided regional anesthesia, prior to needling procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 23, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 23, 2025
CompletedFirst Submitted
Initial submission to the registry
March 7, 2025
CompletedFirst Posted
Study publicly available on registry
March 17, 2025
CompletedMarch 17, 2025
March 1, 2025
1 month
March 7, 2025
March 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Performance assessment of anatomical landmark detection and highlighting of Nerveblox Software
The proportion of structures correctly identified by the software to all structures
Up to 35 days from enrollment
Secondary Outcomes (1)
Image quality assessment
Up to 35 days from enrollment
Study Arms (1)
U.S. Population
OTHERInterventions
Eligibility Criteria
You may qualify if:
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- In good general health
You may not qualify if:
- Pregnancy
- Inability to lie to flat
- Any complaint or anatomical deformity on the regions to be scanned
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AABP Integrative Pain Care and Wellness Clinic
Brooklyn, New York, 11204, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Gary Scott Shwartz, M.D.
AABP Integrative Pain Care and Wellness Clinic, Brooklyn
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 7, 2025
First Posted
March 17, 2025
Study Start
January 13, 2025
Primary Completion
February 23, 2025
Study Completion
February 23, 2025
Last Updated
March 17, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share